Standard BioTools Inc
(NAS:LAB)
$
1.63
-0.12 (-6.86%)
Market Cap: 606.78 Mil
Enterprise Value: 329.93 Mil
PE Ratio: 0
PB Ratio: 1.24
GF Score: 54/100 Fluidigm Corp at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021 / 06:00PM GMT
Release Date Price:
$5.56
(-3.47%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Welcome. Dan Brennan on Day 2 of our Global Healthcare Conference for UBS. Really pleased to be joined with me here at 2:00 p.m. virtual presentation slot with Chris Linthwaite, CEO of Fluidigm. We might be having Vikram, CFO, join as well. We'll hear from them in a moment. But nonetheless, having Chris on stage with me, will be terrific, particularly following their event yesterday, their Investor Day and they're hosting, I believe, a user or a customer group meeting today. So maybe with that introduction, Chris, welcome.
Stephen Christopher Linthwaite
Fluidigm Corporation - President, CEO & Director
Thanks, Dan. I want just to thank you again for you and UBS for including us in your health care conference.
Questions & Answers
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Awesome. So series of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot